Tyrosine Amide and Triazaspirocyclic Antimalarials Are Resistant to the Mutant Plasmodium falciparum Cyclic Amine Resistance Locus (PfCARL)

Abstract Tyrosine amide and triazaspirocyclic chemotypes were identified via high-throughput screening against P. falciparum parasites. Chemical synthesis confirmed potently active stereoisomers for both hit classes. Whole-genome sequencing of resistant lines, combined with pooled resistance barcoding, revealed distinct mutations in the cyclic amine resistance locus (PfCARL) and the UDP-galactose transporter (PfUDP), two ER transmembrane proteins previously associated with resistance to the clinical candidate KAF156. Live-cell thermal proteome integral solubility assays suggest that these compounds target proteins connected with ER-mediated trafficking, supporting the role of PfCARL and PfUDP as multidrug resistance loci rather than direct targets. Both chemotypes disrupted protein export, arrested parasites from late ring-to-early trophozoite stages, and inhibited liver schizont and gamete development. In addition, both tyrosine amide and triazaspirocyclic analogs exhibited high solubility and metabolic stability, highlighting their promise for future development as next-generation multistage antimalarials.

Authors

Institutions

Publication Details

Journal
ACS Infectious Diseases
Published
2026-11-13
DOI
https://doi.org/10.1021/acsinfecdis.6c00764
Primary Topic
Malaria Research and Control
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Tyrosine Amide and Triazaspirocyclic Antimalarials Are Resistant to the Mutant Plasmodium falciparum Cyclic Amine Resistance Locus (PfCARL)

Marcus C. S. Lee, Stephen Brand, Elodie Chenu, Mufuliat Toyin Famodimu et al.
2 links
ACS Infectious Diseases
Malaria Research and Control
article

Tyrosine Amide and Triazaspirocyclic Antimalarials Are Resistant to the Mutant Plasmodium falciparum Cyclic Amine Resistance Locus (PfCARL)

Marcus C. S. Lee, Stephen Brand, Elodie Chenu, Mufuliat Toyin Famodimu, Hannah Jagoe, Jon Kyle Awalt, Delphine Baud, Paul Jackson, Alan F. Cowman, Jonathan Michael White, Kate E. Jarman, Anthony T. Papenfuss, Rachael Coyle, Judith M. Bolscher, Brad E. Sleebs, Rebecca C. S. Edgar, Jocelyn Sietsma Penington, Michael J. Delves, James Duffy, Madeline G. Dans, Jerzy Michal Dziekan, Alfred W. Bronkhorst, Rianne van der Laak, Katie Loi, Qingmiao Zhou
article en

Abstract

Abstract Tyrosine amide and triazaspirocyclic chemotypes were identified via high-throughput screening against P. falciparum parasites. Chemical synthesis confirmed potently active stereoisomers for both hit classes. Whole-genome sequencing of resistant lines, combined with pooled resistance barcoding, revealed distinct mutations in the cyclic amine resistance locus (PfCARL) and the UDP-galactose transporter (PfUDP), two ER transmembrane proteins previously associated with resistance to the clinical candidate KAF156. Live-cell thermal proteome integral solubility assays suggest that these compounds target proteins connected with ER-mediated trafficking, supporting the role of PfCARL and PfUDP as multidrug resistance loci rather than direct targets. Both chemotypes disrupted protein export, arrested parasites from late ring-to-early trophozoite stages, and inhibited liver schizont and gamete development. In addition, both tyrosine amide and triazaspirocyclic analogs exhibited high solubility and metabolic stability, highlighting their promise for future development as next-generation multistage antimalarials.

ACS Infectious Diseases
The University of Melbourne (AU), University of Dundee (GB), Walter and Eliza Hall Institute of Medical Research (AU), Wellcome Sanger Institute (GB), London School of Hygiene & Tropical Medicine (GB), TropIQ Health Sciences (NL), Janssen Research & Development (United States) (US), Medicines for Malaria Venture (CH)
Howard Hughes Medical Institute, Medicines for Malaria Venture, China Scholarship Council, Walter and Eliza Hall Institute, National Health and Medical Research Council
Good health and well-being
Malaria Research and Control
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon